4.3 Article

Effects of 17-Hydroxyprogesterone on Tumor Necrosis Factor-α-Induced Hypertension During Pregnancy

Related references

Note: Only part of the references are listed.
Letter Peripheral Vascular Disease

Cardiotrophin-1 in adolescents: Impact of obesity and blood pressure

Christian Jung et al.

HYPERTENSION (2008)

Review Peripheral Vascular Disease

Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia

Babbette D. LaMarca et al.

HYPERTENSION (2008)

Review Obstetrics & Gynecology

Mechanisms of progesterone action in inhibiting prematurity

Anna K. Sfakianaki et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2006)

Article Biochemistry & Molecular Biology

Prevention and treatment of pregnancy-induced hypertension (preeclampsia) with progestogens

MB Sammour et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)

Review Peripheral Vascular Disease

Preeclampsia - Recent insights

JM Roberts et al.

HYPERTENSION (2005)

Article Peripheral Vascular Disease

Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats

BBD LaMarca et al.

HYPERTENSION (2005)

Article Medicine, General & Internal

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate

PJ Meis et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Reproductive Biology

TNFα-induced apoptosis and integrin switching in human extravillous trophoblast cell line

K Fukushima et al.

BIOLOGY OF REPRODUCTION (2003)

Article Peripheral Vascular Disease

Summary of the NHLBI Working Group on research on hypertension during pregnancy

JM Roberts et al.

HYPERTENSION (2003)